Toripalimab Combined With Neoadjuvant Chemoradiotherapy as First-line Treatment for Locally Advanced，High-Risk，MSS Rectal Cancer
Clinical trial NCT05877573 · UNKNOWN
Trial details
- NCT number
- NCT05877573
- Sponsor
- Nanfang Hospital, Southern Medical University
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-01
- Primary completion
- 2025-01-01
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.